Learn more

NAT CEREBRAL & CARDIOVASCULAR CT

Overview
  • Total Patents
    241
  • GoodIP Patent Rank
    11,397
  • Filing trend
    ⇩ 42.0%
About

NAT CEREBRAL & CARDIOVASCULAR CT has a total of 241 patent applications. It decreased the IP activity by 42.0%. Its first patent ever was published in 2002. It filed its patents most often in Japan, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION, CHILDREN'S MEDICAL CENTER CORP and UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION.

Patent filings per year

Chart showing NAT CEREBRAL & CARDIOVASCULAR CTs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Nakayama Yasuhide 100
#2 Nemoto Yasushi 72
#3 Iwai Ryosuke 46
#4 Kangawa Kenji 23
#5 Nojiri Takashi 20
#6 Oie Tomonori 19
#7 Hosoda Hiroshi 19
#8 Yamaoka Tetsuji 18
#9 Sawamura Tatsuya 13
#10 Tatsumi Eisuke 13

Latest patents

Publication Filing date Title
JP2020137527A Method for manufacturing cell culture vessel
WO2020067170A1 Antitumor effect potentiator
JP2020195690A Output program, output device, output method, and generation method
JP2019080580A Production method and cryopreservation method of amniotic mesenchymal cell composition, and therapeutic agent
JP2020092660A Methods for predicting onset risk of brain infarction
WO2020121489A1 Method for predicting brain infarction onset risk
JP2020079745A Planar image generation device
EP3633036A1 Antisense nucleic acid targeting pcsk9
WO2018143444A1 Verification method and verification system for interal organ model
JP2019076460A Cerebral blood flow measurement method and measurement apparatus
JP2018072337A Method of predicting recurrence risk of major adverse cardiac event
JP2018043983A Compound comprising biodegradable oligomer, hydrophilic segment and cell adhesive peptide, and utilization thereof
JP2019019185A Gelling composition and gel structure
WO2018008770A1 Method for controlling peripheral nerve, method for developing function to alter function of nerve cell in organs excluding brain and spinal cord and others, novel method for preventing or treating disease, and medicine for application to peripheral nerves
WO2017204163A1 Drug for preventing or suppressing lung damage
KR20190004336A Drugs for the prevention and / or treatment of dementia
JP2018121760A Use of peptide specifically binding to vascular endothelial cells and peptide
US2019040359A1 Cell mass, cell structure, and three-dimensional tissue body
WO2017131241A1 Cell cluster, cell structure, and three-dimensional tissue body
JP2018102266A Cell proliferation/differentiation inducing method